Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient.
A 43-year-old man developed the nephrotic syndrome 26 months after allogeneic bone-marrow transplantation for chronic myeloid leukemia. This occurred during an exacerbation of graft-versus-host disease (GVHD) and both problems remitted after therapy with cyclosporine and prednisolone. Renal biopsy showed ultrastructural and immunofluorescence evidence of membranous nephropathy. Anti-nuclear antibodies (but not antiglomerular or anti-renal tubular epithelial antibodies) were detected in his serum. Experimental GVHD in mice has been associated with immune complex glomerulonephritis and the presence of IgG autoantibodies which has been attributed to abnormal T (donor)/B (recipient) cell co-operation. This association can be extrapolated to the human GVHD where autoantibody formation is better described than immune complex glomerulonephritis.
Barbara
J A
JA
Renal Unit, Royal Adelaide Hospital, South Australia.
Thomas
A C
AC
Smith
P S
PS
Gillis
D
D
Ho
J O
JO
Woodroffe
A J
AJ
D000328:Adult; D000974:Antibodies, Antinuclear / Q000276:immunology*; D001706:Biopsy; D016026:Bone Marrow Transplantation / Q000276:immunology*; D016572:Cyclosporine / Q000627:therapeutic use; D005455:Fluorescent Antibody Technique; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy / Q000276:immunology*; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007668:Kidney / Q000473:pathology; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use
D000974:Antibodies, Antinuclear; D016572:Cyclosporine; D011239:Prednisolone